The Merck Foundation has launched the Collaborative for Equity in Cardiac Care, a $22 million, five-year initiative.

Circle Pharma Inc., a clinical-stage biopharmaceutical company, has appointed Rob Lauzen as Chief Financial Officer (CFO).

Sotio Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, promoted Vivi Boura, M.D., Ph.D., an oncologist with experience leading the clinical development of novel cancer therapies ...

G-Rex based manufacturing process to produce gene-modified regulatory T cell (Treg) therapies for autoimmune disorders ...

Ardena, a CDMO and CRO, has appointed Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer.

Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...

Eli Lilly and Company has announced plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Puerto Rico.

Debiopharm has entered a strategic research collaboration with NetTargets to design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-gen ADCs.

The certification highlights the company’s adherence to rigorous safety and traceability protocols within the cell and gene therapy supply chain.

Agreement expands Piramal’s payload-linker platform and bioconjugate abilities.

New services enable early assessment of compound safety and neurotoxic risk in drug discovery.

Mencfeld, CEO of Rezon Bio, was awarded the Woman of the Year title at the 2025 CPHI Pharma Awards at CPHI Frankfurt.